Suppr超能文献

甲状腺功能亢进症中能量平衡的介质。

Mediators of energy homeostasis in hyperthyroidism.

机构信息

Department of Medicine, Karnataka Institute of Medical Sciences, Huballi, India.

Department of Endocrinology and Metabolism, All India Institute of Medical Sciences, Mangalagiri, India,

出版信息

Arch Endocrinol Metab. 2022 Nov 17;66(6):808-814. doi: 10.20945/2359-3997000000511. Epub 2022 Aug 4.

Abstract

OBJECTIVE

The aim of this study was to assess the effect of hyperthyroidism and its treatment on body weight and composition, insulin resistance, and mediators of appetite and energy homeostasis, namely ghrelin, leptin, adiponectin, and fibroblast growth factor 21 (FGF21).

SUBJECTS AND METHODS

Thirty-five adult patients (27 female and 8 male, aged 39.63 ± 9.70 years) with overt hyperthyroidism were evaluated for leptin, ghrelin, adiponectin, and FGF21 levels; insulin resistance; and body composition using DEXA both at baseline and a minimum of two months following normalization of serum thyroxin on carbimazole treatment. Comparison of means between the baseline and post treatment values was performed by the paired t test for normally distributed parameters and by the Wilcoxon signed-rank test for non-normally distributed data.

RESULTS

Hyperthyroidism correction resulted in an increase in weight from 51.15 ± 8.50 kg to 55.74 ± 8.74 kg ( < 0.001), paradoxically accompanied by a decrease in insulin resistance as measured by HOMA-IR from 1.35 (1.02-1.72) to 0.73 (0.52-0.93) ( < 0.001). Correction of hyperthyroidism was also associated with a decrease in FGF21 from 58 (55-64) to 52 (47-58) pg/mL ( < 0.001) and in leptin levels from 17 (7-36) to 11 (4.6-28) ng/mL ( = 0.03).

CONCLUSION

Despite lower body weight, thyrotoxicosis is associated with insulin resistance. High levels of thermogenic hormones, leptin, and FGF21 were observed in thyrotoxicosis and may be partly responsible for the excessive heat production typical of this condition.

摘要

目的

本研究旨在评估甲状腺功能亢进及其治疗对体重和成分、胰岛素抵抗以及食欲和能量稳态的介质(即 ghrelin、瘦素、脂联素和成纤维细胞生长因子 21(FGF21))的影响。

受试者和方法

35 名成年甲状腺功能亢进患者(27 名女性和 8 名男性,年龄 39.63 ± 9.70 岁)接受了瘦素、ghrelin、脂联素和 FGF21 水平、胰岛素抵抗以及使用 DEXA 评估身体成分,基线时和卡比马唑治疗后血清甲状腺素正常化至少两个月。使用配对 t 检验对正态分布参数和 Wilcoxon 符号秩检验对非正态分布数据进行比较均值。

结果

甲状腺功能亢进症的纠正导致体重从 51.15 ± 8.50 kg 增加到 55.74 ± 8.74 kg(<0.001),但出乎意料的是,HOMA-IR 衡量的胰岛素抵抗从 1.35(1.02-1.72)降低到 0.73(0.52-0.93)(<0.001)。甲状腺功能亢进症的纠正还与 FGF21 从 58(55-64)降至 52(47-58)pg/mL(<0.001)和瘦素水平从 17(7-36)降至 11(4.6-28)ng/mL(=0.03)有关。

结论

尽管体重较低,但甲状腺毒症与胰岛素抵抗有关。在甲状腺毒症中观察到高浓度的产热激素、瘦素和 FGF21,它们可能部分解释了这种情况的典型过度产热。

相似文献

1
Mediators of energy homeostasis in hyperthyroidism.甲状腺功能亢进症中能量平衡的介质。
Arch Endocrinol Metab. 2022 Nov 17;66(6):808-814. doi: 10.20945/2359-3997000000511. Epub 2022 Aug 4.

引用本文的文献

1
Relationship between ghrelin and thyroid disease: a meta-analysis.胃饥饿素与甲状腺疾病的关系:一项荟萃分析。
Front Endocrinol (Lausanne). 2025 Feb 28;16:1505085. doi: 10.3389/fendo.2025.1505085. eCollection 2025.

本文引用的文献

3
Effects of thyroid hormones on thermogenesis and energy partitioning.甲状腺激素对产热和能量分配的影响。
J Mol Endocrinol. 2018 Apr;60(3):R157-R170. doi: 10.1530/JME-17-0319. Epub 2018 Feb 6.
5
Fibroblast growth factor-21, energy balance and obesity.成纤维细胞生长因子-21、能量平衡与肥胖
Mol Cell Endocrinol. 2015 Dec 15;418 Pt 1:66-73. doi: 10.1016/j.mce.2015.09.018. Epub 2015 Sep 26.
9
Thyroid hormone regulation of metabolism.甲状腺激素对代谢的调节。
Physiol Rev. 2014 Apr;94(2):355-82. doi: 10.1152/physrev.00030.2013.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验